Financial Analyst & Trader (since 2011) | 200+ reports on Seeking Alpha, Investing, Benzinga | Deep fundamental analysis of Macro, AI & Income strategies📈
Cite asCryptoQuant has tracked the directional calls on 000660 by @Dmytro_Lebid on X since Mar 2026: not yet scored on 000660 (as of Nov 11, 2026).
Other assets covered (20)
5 000660 calls on record, a thin history.
Relative view by default: fewer than 30 000660 calls or days on record.
Sentiment timeline shows relative sentiment within this analyst's history. A perma-bull showing 8 bullish : 2 bearish in a bear market sets that as their baseline. If you notice any errors, claim @Dmytro_Lebid to submit corrections.
Hover the chart to read the thesis of that period · click a day to pin it
UBS Group AG, Switzerland’s largest investment bank, increased its stake in $AAOI by 28.3% in Q3 2026. The bank’s total holding stands at 2,708,253 shares. The total investment amounts to $268.82M. It is AAOI’s largest institutional investor as of the interim Form 13F filing for Q3 2026.
View original →Morgan Stanley is among $SIVE’s major investors. However, this information should not be interpreted to mean that "Morgan Stanley purchased an 8.45% stake in Sivers for its investment portfolio." Morgan Stanley’s presence should be understood as representing custodial pools containing funds from U.S. and European retail investors. For example, MORGAN STANLEY & CO INTL PLC is the British division of Morgan Stanley, headquartered in London. And Form W-8IMY confirms that the bank acts as an intermediary, not the ultimate beneficial owner of the securities. MORGAN STANLEY SMITH BARNEY LLC is the "American twin" of the previous account, but it serves a completely different category of clients. While the London-based unit focuses on international prime brokerage and derivatives, Smith Barney LLC specializes in purely U.S.-based wealth management and retail brokerage (including E*TRADE) for U.S. tax residents. If we combine the share held by the U.S. division with that of MERRILL LYNCH, PIERCE, FENNER & SMI, a striking picture emerges for the Swedish tech startup: 6.67% of all SIVE shares have been purchased by U.S. retail investors. It is precisely this interest from American capital (fueled by the buzz around silicon photonics and AI chips) that explains why U.S. brokerage firms have edged out Swedish pension and retail platforms in the list of major investors, such as Avanza (2.14% stake).
View original →$RKLB's backlog soared 52% over the quarter to a record $3.57B, while revenue reached $268M (+73% YoY). Let's run through my report based on the 4 checkpoints from my preview: Neutron and R&D: The first launch won’t happen until at least 2027, but customers are voting with their wallets—in Q3, contracts worth $515+M were signed (with 16 missions in the pipeline), and the base launch price was raised from $55M to $70M amid a capacity shortage. The second stage and Thrust Module are already at LC-3, but peak expenses have not yet been reached: Non-GAAP R&D expenses rose from $75.5M to $92.7M. Space Systems Margin: Segment revenue reached $214.8M due to the conversion of SDA Tranche II/III defense contracts, and the backlog grew to $1.7B. The gross margin easily exceeded the 30% target: 33.5% on a GAAP basis (38.4% on a non-GAAP basis), with a Q4 forecast of 34–36% on a GAAP basis (39–41% on a non-GAAP basis). Electron Pace: Assembly accelerated to 1 rocket every 8 days (+37.5% YoY), with the 100th launch scheduled for November 14. Cash Flow and EBITDA: Operating cash flow (GAAP OCF) turned positive at $7.2M (up $91.2M QoQ) and reduced the FCF outflow from $110.1M to $23.9M. Adjusted loss EBITDA loss widened to $18M (Q4 guidance: -$14M…-$20M) due to Neutron-related expenses. The increase in Neutron’s price to $70M even before the first flight fully offsets the launch delay to 2027. The balance sheet shows $4.71B in liquidity; the Iridium acquisition is fully funded and awaits only final regulatory approval. With Q4 revenue guidance of $270–290M, short sellers (7.57% of short interest) remain under intense pressure.
View original →I’ve analyzed $ASTS’s quarterly report for Q3 2026. And I can say that we’re seeing a clash between "a local revenue shortfall and launch delays" vs. "$1B of non-dilutive capital and our own rocket." Now, let’s go through the four indicators of management discipline that I highlighted in the preview: 1. Maths of Gaidans ($150–200M): Q3 revenue came in at just $42.3M—below consensus ($45.7M) and our threshold ($50M+). The full-year forecast remains unchanged, but Q4 now requires a record-breaking surge to $61.4M+ driven by gateway shipments and government contracts. 2. Launch Schedule: The target of ~45 satellites has officially been pushed back from early to mid-2027. BB 14–16 are still awaiting dates from $SPCX, while BB 17–25 are scheduled for Q1 2027. In return, management has accelerated the rollout of ASIC chips through BB 34 (reaching a production rate of 6 units per month in December) and announced its own 20-metric-ton Blacklift rocket by the end of 2028. 3. Contracts: The beam handover with AT&T was successfully validated, and the company received DPAS defense priority and a ~$100M Space Force contract. 4. Cash Burn: Liquidity stands at $3.2B. Quarterly CapEx fell to $310.4M (from $610.4M in Q2), while adjusted OpEx rose to $133.6M. The key asset is $1.0B in non-dilutive funding from the Japanese government. My verdict: The $1B from Japan and DPAS status eliminate the risk of a rights offering, offsetting weak Q3 2026 revenue. However, the development of its own Blacklift rocket could trigger a new cycle of heavy capital expenditures given an extreme valuation of >90x EV/Sales.
View original →Bank of Montreal doubled its investment in $NBIS (by 102%), while its position in $IREN was reduced by 17.2%. According to the latest 13F filing, the number of NBIS shares held increased to 1.066M, representing approximately $251.67M. Bank of Montreal also purchased 630,500 put options on NBIS. The stake in IREN was reduced to 1.768M shares, valued at approximately $72.29M. However, derivatives were also purchased for IREN: 1.265M put options and 0.824M call options.
View original →
